Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhNRG-1 Survival Study in Chronic Systolic Heart Failure
NCT01541202Phase 3Terminated
- Sponsor
- Zensun
- Start
- Feb 2012
- Primary completion
- Aug 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of neucardin in chronic systolic heart failure (HFrEF), sponsored by Zensun. Started Feb 2012; status: terminated.
02
Drugs
neucardin
03
Conditions
chronic systolic heart failure (HFrEF)
Beyond the preview
Go deeper on NCT01541202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01541202.